Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Franziska Westendorf

10PUBLICATIONS

80CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Other biomedical and clinical sciences not elsewhere classified

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Sep 27, 2025

Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity Therapy.

Katja Krüger, Razif Gabdoulline, Martin Wichmann

|Jul 21, 2025

Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.

Julian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch

|Jan 08, 2025

A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents.

Rabia Shahswar, Razif Gabdoulline, Katja Krueger

|Nov 09, 2024

Murine Regulatory CD4<sup>+</sup> T Cells Are Increased in Leukemic Spleens and Show High Co-Expression of Co-Regulatory Molecules CD39, CD73, PD1, and TIGIT.

Julius Krüger, Jasmin Wellbrock, Marius Witt

|Nov 24, 2023

Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures.

Melanie Schoof, Shweta Godbole, Thomas K Albert

|Mar 14, 2023

Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia.

Adrian Gottschlich, Moritz Thomas, Ruth Grünmeier

Pageof 2

Frequent Collaborators

5 joint publications

Walter Fiedler

3 joint publications

Carsten Bokemeyer

3 joint publications

Susanne Ghandili

2 joint publications

Holger Rohde

2 joint publications

Christoph Röllig

2 joint publications

Felicitas Thol

2 joint publications

Andreas Voß

1 joint publications

Rabia Shahswar

1 joint publications

Steffen Härterich

1 joint publications

Moritz Thomas

Frequent Collaborators

5 joint publications

Walter Fiedler

3 joint publications

Carsten Bokemeyer

3 joint publications

Susanne Ghandili

2 joint publications

Holger Rohde

Top Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>

Published on : Feb 09, 2016

See more related videos

Top Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>

Published on : Feb 09, 2016

See more related videos